CoraLite® Plus 488-conjugated PLDN Monoclonal antibody
PLDN Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG1
Reactivity
Human, Mouse, Rat
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
4F4C11
Cat no : CL488-66558
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL488-66558 targets PLDN in IF/ICC applications and shows reactivity with Human, Mouse, Rat samples.
Tested Reactivity | Human, Mouse, Rat |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | PLDN fusion protein Ag18095 |
Full Name | pallidin homolog (mouse) |
Calculated Molecular Weight | 23~24 kDa |
Observed Molecular Weight | 26 kDa |
GenBank Accession Number | BC004819 |
Gene Symbol | PLDN |
Gene ID (NCBI) | 26258 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Pallidin, also named as PLDN and PA, is involved in the development of lysosome-related organelles, such as melanosomes and platelet-dense granules. It may play a role in intracellular vesicle trafficking, particularly in the vesicle-docking and fusion process. Pallidin interacts with syntaxin-12 which is a t-SNARE protein that mediates vesicle docking and fusion.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 PLDN antibody CL488-66558 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |